Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trelagliptin succinate tablets in type 2 diabetes mellitus
CTR20170649Phase 3Completed
- Sponsor
- Nanjing Wanchuan Pharmaceutical
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trelagliptin in type 2 diabetes mellitus (T2DM), sponsored by Nanjing Wanchuan Pharmaceutical. Started Aug 2017; status: completed.
02
Drugs
trelagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20170649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170649.